Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
06:30am, Thursday, 27'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
04:00pm, Tuesday, 25'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
06:30am, Tuesday, 18'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
06:30am, Wednesday, 05'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
06:30am, Tuesday, 21'st Jan 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in men
Compass Pathways Announces Pricing of Underwritten Offering
07:01am, Friday, 10'th Jan 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
06:30am, Wednesday, 18'th Dec 2024
LONDON--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announc
Compass Pathways to Participate in December Investor Conferences
04:00pm, Monday, 25'th Nov 2024
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to participate in Stifel 2024 Healthcare Conference
07:44am, Thursday, 14'th Nov 2024
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced
Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
05:10pm, Friday, 01'st Nov 2024
Compass Pathways plc obtained positive results from phase 2b study using COMP360 for treatment resistant depression patients; Primary endpoint met with statistically significant p-value of p
COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript
02:49pm, Thursday, 31'st Oct 2024
COMPASS Pathways plc (NASDAQ:CMPS ) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - Chief E
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
06:30am, Thursday, 31'st Oct 2024
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in men
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
06:30am, Thursday, 24'th Oct 2024
LONDON--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announc
Compass Pathways to participate in three investor conferences in September
06:00am, Wednesday, 28'th Aug 2024
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced
Psychedelic Stocks: Focus On Their Cash
12:30pm, Thursday, 15'th Aug 2024
Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and MindMe
